Currently, pharmacologic agents for osteoporosis are mainly divided into antiresorptive drugs to inhibit bone resorption and anabolic drugs to promote bone formation, including bisphosphonates, denosumab, teriparatide, calcitonin and low‐dose parathyroid hormone [27, 28, 29]. Here, PTH is linked to osteoporosis.